Results 231 to 240 of about 800,848 (376)

Performance of goodness-of-fit tests for the Cox proportional hazards model with time-varying covariates

Lifetime Data Analysis, 2014
S. Grant, Ying Q. Chen, S. May
semanticscholar   +1 more source

A new proportional hazard model with applications to breastfeeding data [PDF]

Yolanda M. Gómez, Wilson E. Caimanque, John L. Santibáñez, Rocío Zúñiga-Tapia, Diego I. Gallardo, Marcelo Bourguignon   +5 more
openalex   +1 more source

Amyotrophic Lateral Sclerosis Prevalence Projection in 2040: A Less Rare Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To project ALS prevalence across multiple countries through 2040, accounting for both population aging and increased survival. Methods Data from the Piemonte and Valle d'Aosta ALS register (PARALS) was used to estimate the trends in incidence and prevalence from 2005 to 2019. Survival trends over this period were also assessed.
Rosario Vasta, Stefano Callegaro, Antonio Canosa, Umberto Manera, Maurizio Grassano, Francesca Palumbo, Sara Cabras, Enrico Matteoni, Francesca Di Pede, Filippo De Mattei, Salvatore Tafaro, Neil M. Thakur, Ryan Grosenick, Fabiola De Marchi, Letizia Mazzini, Cristina Moglia, Andrea Calvo, Kuldip D. Dave, Adriano Chiò   +18 more
wiley   +1 more source

Revisiting Factors Influencing Under-Five Mortality in India: The Application of a Generalised Additive Cox Proportional Hazards Model. [PDF]

Int J Environ Res Public Health
Khan MA, Das SK.
europepmc   +1 more source

Proportional Hazards Model With Covariate Measurement Error and Instrumental Variables

Journal of the American Statistical Association, 2014
Xiao Song, Ching-Yun Wang
semanticscholar   +1 more source

Attributable risk function in the proportional hazards model for censored time-to-event [PDF]

, 2006
Ying Qing Chen
openalex   +1 more source

Plasma Proteomic Signatures for Alzheimer's Disease: Comparable Accuracy to ATN Biomarkers and Cross‐Platform Validation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu, Oliver Robinson, Christina M. Lill, Anna Matton, Raquel Puerta, Pilar Sanz, Merce Boada, Agustín Ruiz, Lefkos Middleton, for the Alzheimer's Disease Neuroimaging Initiative   +9 more
wiley   +1 more source

The Proportional Hazard Model and the Modelling of Recurrent Failure Data : Analysis of a Disconnector Population in Sweden

, 2017
Jan Henning Jürgensen, Anna Lilly Brodersson, Patrik Hilber, Lars Nordström   +3 more
openalex   +1 more source

The MMP‐9/TIMP‐1 Ratio and Concentrations of Osteopontin Are Elevated in Cerebrospinal Fluid of People With Multiple Sclerosis and Decrease After Autologous Hematopoietic Stem Cell Transplantation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives To evaluate the utility of cerebrospinal fluid (CSF) biomarkers—matrix metalloproteinase‐9 (MMP‐9), tissue inhibitor of metalloproteinases‐1 (TIMP‐1), the MMP‐9/TIMP‐1 ratio, and osteopontin (OPN)—as indicators of blood–brain barrier (BBB) integrity and disease activity in people with relapsing–remitting multiple sclerosis (pwMS ...
Ivan Pavlovic, Ida Erngren, Kim Kultima, Anders Larsson, Malin Müller, Anna Wiberg, Joachim Burman   +6 more
wiley   +1 more source

Factors affecting the survival of prediabetic patients: comparison of Cox proportional hazards model and random survival forest method. [PDF]

BMC Med Inform Decis Mak
Sharafi M, Mohsenpour MA, Afrashteh S, Eftekhari MH, Dehghan A, Farhadi A, Jafarnezhad A, Zakeri A, Looha MA.   +8 more
europepmc   +1 more source